Showing results (2421-2430 of 3,086) with videos related to
Sort By:
Pageof 309
Drug Safety|June 20, 2002
Use of measures of disproportionality in pharmacovigilance: three Dutch examplesAntoine C G Egberts, Ronald H B Meyboom, Eugène P van PuijenbroekDrug Safety|September 12, 2002
Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative reviewRaheem B Kherani, Alexandra Papaioannou, Jonathan D AdachiDrug Safety|September 10, 2003
Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitisRami Jean Salib, Peter Hugo HowarthDrug Safety|November 14, 2019
Prenatal Exposure to Macrolides and Risk of Congenital Malformations: A Meta-AnalysisNarmeen Mallah, Hamid Reza Tohidinik, Mahyar Etminan, et al.Drug Safety|November 7, 2019
Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web SurveillanceSigal Kaplan, Aurore Bergamasco, Martin Sergerie, et al.Drug Safety|November 7, 2019
Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)Taylor M Patek, Chengwen Teng, Kaitlin E Kennedy, et al.Drug Safety|November 7, 2019
Medical Devices: Classification and Analysis of Faults Leading to HarmsRobin E Ferner, Jeffrey K AronsonDrug Safety|November 8, 2019
Rheumatology Common Toxicity Criteria (RCTC): An Update Reflecting Real-World UseChristian M Stach, Victor S Sloan, Thasia G Woodworth, et al.Drug Safety|December 22, 2019
Hypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS)Kaitlin E Kennedy, Chengwen Teng, Taylor M Patek, et al.Drug Safety|February 13, 2020
Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey StudySieta T de Vries, Petra Denig, Corine Ekhart, et al.Pageof 309